Karyopharm Therapeutics Inc (NASDAQ:KPTI)’s traded shares stood at 0.73 million during the last session, with the company’s beta value hitting 0.09. At the close of
Karyopharm Therapeutics Inc (NASDAQ:KPTI)’s traded shares stood at 1.01 million during the last session, with the company’s beta value hitting 0.09. At the close of
In last trading session, Karyopharm Therapeutics Inc (NASDAQ:KPTI) saw 0.77 million shares changing hands with its beta currently measuring 0.06. Company’s recent per share price
During the last session, Karyopharm Therapeutics Inc (NASDAQ:KPTI)’s traded shares were 0.43 million, with the beta value of the company hitting 0.07. At the end
In today’s recent session, 0.62 million shares of the Karyopharm Therapeutics Inc (NASDAQ:KPTI) have been traded, and its beta is 0.07. Most recently the company’s
Karyopharm Therapeutics Inc (NASDAQ:KPTI)’s traded shares stood at 0.57 million during the last session, with the company’s beta value hitting 0.06. At the close of
In last trading session, Karyopharm Therapeutics Inc (NASDAQ:KPTI) saw 0.85 million shares changing hands with its beta currently measuring 0.06. Company’s recent per share price
During the last session, Karyopharm Therapeutics Inc (NASDAQ:KPTI)’s traded shares were 0.66 million, with the beta value of the company hitting 0.04. At the end
During the last session, Karyopharm Therapeutics Inc (NASDAQ:KPTI)’s traded shares were 2.6 million, with the beta value of the company hitting 0.07. At the end
Karyopharm Therapeutics Inc (NASDAQ:KPTI)’s traded shares stood at 1.61 million during the last session, with the company’s beta value hitting 0.05. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
